FAKTOR OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Stock

Certificat

DE000PX3FME3

Market Closed - Börse Stuttgart 11:53:23 2024-05-31 EDT
0.31 EUR -.--% Intraday chart for FAKTOR OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
6 months-6.06%
Current year-6.06%
Date Price Change
24-05-31 0.31 -.--%
24-05-30 0.31 +6.90%
24-05-29 0.29 -9.38%
24-05-28 0.32 +3.23%
24-05-27 0.31 -.--%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 11:53 am

More quotes

Static data

Product typeWarrant Esotici e Strutturati
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PX3FME
ISINDE000PX3FME3
Date issued 2018-12-05
Strike 39.06
Maturity Unlimited
Parity 0.17 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 10.63
Lowest since issue 0.166
Spread 0.02
Spread %6.06%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39.18 EUR
Average target price
39.92 EUR
Spread / Average Target
+1.89%
Consensus